Vantage Health Announces Corporate Name Change to Vantage mHealthcare, Inc.
10 January 2015 - 7:30AM
Business Wire
Company Amends State of Incorporation to
Delaware
Vantage mHealthcare, Inc. (OTCQB:VNTH) (“Vantage Health” or the
“Company”) today announced that the corporate name has officially
changed to Vantage mHealthcare, Inc. to better align the strategic
direction of the Company within the growing and innovative mobile
healthcare technology sector.
In addition to this name change, the Company has amended its
Certificate of Incorporation such that it is now a Delaware
corporation and it increased its authorized shares outstanding from
250,000,000 to 500,000,000 shares and reclassified such capital
stock into 450,000,000 shares of common stock, par value $0.001,
and 50,000,000 shares of preferred stock, par value $0.001. The
Company has no immediate plans to use the additional shares.
The Company has also adopted Amended and Restated Bylaws which,
along with the amended Certificate of Incorporation, contain
customary public company provisions.
Vantage mHealthcare has officially moved its corporate
headquarters to New York, New York, while continuing operational
headquarters in Mountain View, CA.
About Vantage mHealthcare, Inc.
Vantage mHealthcare, Inc. - a mobile healthcare technology
company - is developing personalized and point-of-care screening
using Apps based upon chemical sensing residing within a Bluetooth
device that works with any smartphone. With its foundations in
advanced nanotechnology, the Company’s first product, the Vantage
Health Sensor, which is in development, is the convergence of
nano-electronics, bio-informatics, and wireless technology to
create the next generation mobile health application. The first
mobile App is expected to be for lung cancer screening with
additional mobile healthcare Apps in the planning stages. The
company has offices in New York City and Mountain View, California.
For more information, please visit
http://www.vantagehealthinc.com.
This press release contains “forward-looking statements” within
the meaning of the Private Securities Litigation Reform Act of 1995
that involve risks and uncertainties that could cause actual
results to be materially different from historical results or from
any future results expressed or implied by such forward-looking
statements. Such forward-looking statements include, among other
things, statements with respect to our objectives and strategies to
achieve those objectives, as well as statements with respect to our
beliefs, plans, expectations, anticipations, estimates or
intentions. Such forward-looking statements may also include
statements, among other things, concerning the efficacy, safety and
intended utilization of Vantage Health’s product candidates, the
conduct and results of future clinical trials, plans regarding
regulatory filings, future research and clinical trials and plans
regarding partnering activities. Factors that may cause actual
results to differ materially include, among others, the risk that
product candidates that appeared promising in early research and
clinical trials do not demonstrate safety and/or efficacy in
larger-scale or later clinical trials, trials may have difficulty
enrolling, Vantage Health may not obtain approval to market its
product candidates, or outside financing may not be available to
meet capital requirements. These forward-looking statements are
based on our current expectations. We caution that all
forward-looking information is inherently uncertain and actual
results may differ materially from the assumptions, estimates or
expectations reflected or contained in the forward-looking
information, and that actual future performance will be affected by
a number of factors, including economic conditions, technological
change, regulatory change and competitive factors, many of which
are beyond our control. Therefore, future events and results may
vary significantly from what we currently foresee.
For a further list and description of the risks and
uncertainties the Company faces, please refer to the Company’s most
recent Annual Report on Form 10-K and other periodic and other
filings Vantage Health files with the Securities and Exchange
Commission and are available at www.sec.gov. Such forward-looking
statements are current only as of the date they are made, and
Vantage assumes no obligation to update any forward-looking
statements, whether as a result of new information, future events
or otherwise.
Investors:CSIR Group, LLC.Christine Petraglia, 212-386-7082
Nano Mobile Healthcare (PK) (USOTC:VNTH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Nano Mobile Healthcare (PK) (USOTC:VNTH)
Historical Stock Chart
From Jul 2023 to Jul 2024